CureDiab at the 82nd Scientific Session of the American Diabetes Association (ADA) 2022

16. Mai 2022

Very soon, we will present our discovery about the hepatoprotective activity of positive allosteric modulators of the GABAA receptor in the international congress of the ADA in New Orleans, Louisiana. We are looking forward to join interesting talks and discuss about the latest updates on drug development for NAFLD. Don’t hesitate to contact us and meet us there.